A counterintuitive antibody cocktail disrupts coxsackievirus.

Zost, Seth J; Vogt, Matthew R

Zost, Seth J; Vogt, Matthew R.

Zost SJ; Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN, USA.
Vogt MR; Department of Pediatrics, Division of Infectious Diseases, and Department of Microbiology & Immunology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA. Electronic address: mrvogt@unc.edu.

Cell Host Microbe ; 30(9): 1194-1195, 2022 09 14.

Article in English | MEDLINE | ID: covidwho-2027966

ABSTRACT

ABSTRACT

Utilizing monoclonal antibodies to prevent and treat infectious diseases has been accelerated by the COVID-19 pandemic. In this issue of Cell Host & Microbe, Zheng et al. show how a three-monoclonal-antibody cocktail, that defies conventions of "rational design" for a therapeutic agent, functions cooperatively to disrupt coxsackievirus virions.

Subject(s)

COVID-19; Enterovirus; Antibodies, Monoclonal/therapeutic use; Humans; Pandemics; Virion

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Enterovirus / COVID-19 Limits: Humans Language: English Journal: Cell Host Microbe Journal subject: Microbiology Year: 2022 Document Type: Article Affiliation country: J.chom.2022.08.010

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google